Yahoo Finance report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
Why CDRE Stock dropped -2.38% Today — RQD Quant Desk Flash
Cadre Holdings Inc. (CDRE) carries a Roarable Rating of C (Hold) with 62/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is CDRE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Cadre Holdings Inc. (NYSE: CDRE) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 62/100 at a spot price of $30.36 (-2.38% 1D, market cap $1.30B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 14/20. Across 1016 tracked Health Care issuers, CDRE ranks #151 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does CDRE compare to ENOV and ESTA in the Health Care sector?
▼
Within the Health Care sector (Industrial Specialties), CDRE carries a Roarable C (62/100 RQD), trailing P/E of 30.2x, gross margin of 42.5%, and ROIC of 11.0%. By comparison, ENOV (Enovis Corporation) holds a D- grade (38/100 RQD, P/E N/A, ROIC -32.7%, cap $1.15B) and ESTA (Establishment Labs Holdings Inc.) posts a E grade (26/100 RQD, P/E N/A, ROIC -15.8%, cap $1.86B). Among the 5-stock peer group, CDRE leads on earnings multiple (30.2x) while CDRE leads on capital efficiency (11.0% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for CDRE?
▼
Per CDRE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001860543), Cadre Holdings Inc. generated $610.3M in revenue (+7.5% YoY), $44.1M in net income, and $56.8M in free cash flow against $770.0M in total assets and $291.0M in total debt. Key quantitative strengths: Strong cash generator (43% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
SEC XBRL FY 2025 (10-K): 9.3% FCF Margin ($56.8M FCF) & 42.5% Gross Margin
Altman Z-Score 3.32 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 9/9
Macro rate sensitivity & RSI-14 (62.1) create a -13 pt regime headwind
⚔️ Adversarial Opposing Case: Why the CDRE Bull Thesis Could Fail
Even with a 62/100 (C) score, CDRE faces multiple-compression risk if 30.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Sensitive to high interest rates and tighter Federal Reserve market liquidity.
Dilution & Margin Drag: Cannibal Buyback (-1.80% YoY Shares) — any gross margin slip below 40.0% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($27.84) or 200D SMA ($32.09) invalidates the momentum regime and cuts Target Base ($30.91) toward Bear Floor ($24.11).
Why CDRE Stock dropped -2.38% Today — RQD Quant Desk Flash
Cadre Holdings Inc. (CDRE) dropped -2.38% to $30.36, trading at 25% of its 52-week range ($24.07 – $48.76). Solid 43% profit margin (11% return on capital), mixed timing at 30x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 25% of its 52-week range ($24.07 – $48.76) with RSI-14 at 62.1 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±8.8% around $30.36 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C (Hold) backed by 42.5% gross margin and $56.8M annual free cash flow.
Seeking Alpha report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
Moomoo report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
StockStory report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
Stock Traders Daily report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
https://www.siam.in/ report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
For questions about this article or underlying research, email help@trefis.com.
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit
Scheduled RQD Strong Buys & Whale Accumulation Briefing (CDRE Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
CDRE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +7.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CDRE today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CDRE. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CDRE)
1. Head-to-Head Health Care Peer Comparison (CDRE vs. ENOV, ESTA, AVR, ZJYL)
Industry: Industrial Specialties (55 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Cadre Holdings Inc. (CDRE) ranks #151 by composite RQD confidence (62/100, grade C) and #324 by equity capitalization ($1.30B). Within this direct 5-issuer industry benchmark cohort, CDRE leads on earnings valuation at 30.2x trailing P/E, while CDRE leads on capital efficiency and profitability with 11.0% ROIC and 42.5% gross margin. CDRE currently leads its immediate peer cohort in composite quantitative strength at 62/100 (C).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| CDRE
ACTIVE
Cadre Holdings Inc. | C | 62/100 | 30.2x | 42.5% | 11.0% | -2.38% | $1.30B | Benchmark Subject |
| ENOV Enovis Corporation | D- | 38/100 | — | 59.8% | -32.7% | -12.71% | $1.15B | /enov-vs-cdre → |
| ESTA Establishment Labs Holdings Inc. | E | 26/100 | — | 69.3% | -15.8% | -8.70% | $1.86B | /esta-vs-cdre → |
| AVR Anteris Technologies Global Corp. | E | 22/100 | — | 70.3% | -35.0% | -1.71% | $615.2M | /avr-vs-cdre → |
| ZJYL JIN MEDICAL INTERNATIONAL LTD. (Class A) | D | 46/100 | — | 29.2% | — | +26.34% | $371.8M | /zjyl-vs-cdre → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001860543In its most recent audited fiscal period (FY2025, filed 2025-12-31), Cadre Holdings Inc. (CDRE) reported GAAP revenue of $610.3M (+7.5% vs. FY2024 revenue of $567.6M , and +26.5% cumulative change since FY2023) , GAAP net income of $44.1M, operating cash flow of $63.7M, and free cash flow of $56.8M (+117.7% YoY). On the balance sheet, CDRE closed FY2025 with $770.0M in total assets against $291.0M in total debt (Altman Z-Score: 3.32, Piotroski F-Score: 9/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $610.3M | $44.1M | $63.7M | $56.8M | $770.0M | $291.0M |
| FY2024 (FY) | 2024-12-31 | $567.6M | $36.1M | $31.8M | $26.1M | $652.7M | $211.8M |
| FY2023 (FY) | 2023-12-31 | $482.5M | $38.6M | $73.2M | $73.2M | — | — |
3. CDRE Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs CDRE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Cadre Holdings Inc. (NYSE: CDRE) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 62/100 at a spot price of $30.36 (-2.38% 1D, market cap $1.30B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 10/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 14/20. Across 1016 tracked Health Care issuers, CDRE ranks #151 in composite RQD confidence.
How does CDRE compare to ENOV and ESTA in the Health Care sector?
Within the Health Care sector (Industrial Specialties), CDRE carries a Roarable C (62/100 RQD), trailing P/E of 30.2x, gross margin of 42.5%, and ROIC of 11.0%. By comparison, ENOV (Enovis Corporation) holds a D- grade (38/100 RQD, P/E N/A, ROIC -32.7%, cap $1.15B) and ESTA (Establishment Labs Holdings Inc.) posts a E grade (26/100 RQD, P/E N/A, ROIC -15.8%, cap $1.86B). Among the 5-stock peer group, CDRE leads on earnings multiple (30.2x) while CDRE leads on capital efficiency (11.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for CDRE?
Per CDRE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001860543), Cadre Holdings Inc. generated $610.3M in revenue (+7.5% YoY), $44.1M in net income, and $56.8M in free cash flow against $770.0M in total assets and $291.0M in total debt. Key quantitative strengths: Strong cash generator (43% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is CDRE trading relative to its 50-day, 200-day, and 52-week technical levels?
CDRE last traded at $30.36 (-2.38% on volume of 320,517 shares), positioning the stock +9.05% above its 50-day simple moving average ($27.84) and -5.39% below its 200-day simple moving average ($32.09). Across its 52-week range of $24.07 to $48.76, CDRE sits at the 25.5% percentile with a 14-day RSI of 62.1 (BULLISH MOMENTUM) and an implied next-earnings move of ±8.8% ($27.69 to $33.03).
CDRE Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is CDRE stock moving today?
Why CDRE Stock dropped -2.38% Today — RQD Quant Desk Flash. Solid 43% profit margin (11% return on capital), mixed timing at 30x P/E—hold if owned, no rush to chase.
CDRE — Cadre Holdings Inc.: What the Facts Mean to a Prospective Investor
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, CDRE carries an RQD Score of 62, a letter grade of C, and the verdict "Roarable Hold — Fair / Balanced Risk-Reward." The five pillars are scored as follows: Fundamental Cash Engine at 16 of 20 (ROIC 11%; FCF yield 4.27%), Whale 13F Flow at 10 of 20 (institutional accumulation and options positioning), Insider Conviction at 14 of 20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 7 of 20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet at 15 of 20 (Altman Z 3.32; Piotroski F 9/9; Debt/Equity 0.92).
Read together, the strongest pillar is the cash engine, supported by an 11% ROIC and a 4.27% FCF yield, which indicates that the business is generating cash relative to its market value. The forensic balance sheet pillar is also solid, with a Piotroski F-Score of 9/9 and an Altman Z-Score of 3.32, both of which point to financial health per the stated metrics. The weakest pillar is Macro Regime Fit at 7 of 20, which, combined with a Beta of 1.0, suggests the stock's sensitivity to broader market and sector conditions is a meaningful consideration. Whale flow (10 of 20) is moderate, and insider conviction (14 of 20) is positive but not dominant.
The valuation tradeoff is visible in the market data: a P/E (TTM) of 30.2 and a Forward P/E of 28.1 sit well above what a cash-yield lens alone would imply, so upside depends on sustained earnings growth to justify the multiple. The overall grade of C and "Hold" verdict reflect a balance between a quality balance sheet and cash generation on one side and an elevated multiple and market-sensitive profile on the other. This is an analytical summary of the scoring framework, not personalized financial advice.
Snapshot
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $610.3M | $67.4M | $44.1M | N/A | $56.8M | $122.9M | $291.0M |
| FY 2024 | $567.6M | $66.8M | $36.1M | N/A | $26.1M | $124.9M | $211.8M |
| FY 2023 | $482.5M | $56.5M | $38.6M | N/A | $73.2M | N/A | N/A |
Per the SEC financials, revenue rose from $482.5M in FY 2023 to $610.3M in FY 2025, and net income moved from $38.6M to $44.1M over the same span, with FY 2024 net income at $36.1M. Operating income was $67.4M in FY 2025 against $66.8M in FY 2024. Debt increased from $211.8M to $291.0M across FY 2024 to FY 2025, while reported cash moved from $124.9M to $122.9M. Per the Roarable RQD rating and market data, ROIC is 11%, the Altman Z-Score is 3.32, the Piotroski F-Score is 9/9, and Debt/Equity is 0.92.
Recent Catalysts & News Wire Analysis
Per the recent news and catalysts section, the items are as follows:
- CATALYST (GREEN): A Yahoo Finance report headlined "Cadre (CDRE) Stock Could Be A Bargain On Cash Flow."
- RISK WATCH (RED): A Seeking Alpha report headlined "Cadre Holdings: A Risky M&A Strategy Worth Betting On," flagged as a risk item.
- MARKET WIRE (YELLOW): Items from Moomoo (options chain), Yahoo Finance (quarterly dividend of $0.10 per share), MarketBeat (price and analysis), and StockStory ("2 Small-Cap Stocks Worth Investigating and 1 Facing Challenges").
Per the Butterfly Supply-Chain Graph, the supply chain is recorded as NONE, with no butterfly links and no proprietary signals.
Open Questions
- What are the company's specific products, end markets, and customer concentration, given the source data gives only a sector classification?
- What drove the FY 2025 debt increase to $291.0M, and what is the M&A activity referenced in the news wire?
- What are the reported EPS figures for each period, since the source lists EPS as N/A?
- What are the FY 2023 cash and debt balances, which are listed as N/A?
- What is the sell-side consensus and institutional ownership profile, given both analyst and holders data are unavailable?
CDRE Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Cadre Holdings Inc. (CDRE) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo Finance report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
Moomoo report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
StockStory report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
Stock Traders Daily report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
https://www.siam.in/ report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.
CDRE Bull vs. Bear Conversation Board — What's Your Call at $30.36?
🔥 Official Bull vs. Bear Debate: Is CDRE (C • RQD 62/100) a Buy at $31.10?
Welcome to the CDRE (Cadre Holdings Inc.) Roar Pit. Current RQD Composite is 62/100 (Roarable Hold — Fair / Balanced Risk-Reward) in Industrial Specialties. Bulls point to operating leverage and sector positioning, while bears focus on valuation multiple compression (30.2x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Pump the brakes on CDRE — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on CDRE, but look at what you are paying: 30.2x trailing P/E with 42.5% gross margins. Unless Cadre Holdings Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
CDRE cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on CDRE, the market is fixating on short-term headline noise in Industrial Specialties and ignoring the balance sheet and cash flow trajectory. At $31.10 (52-wk range $24.07 - $48.76), any beat on forward guidance forces shorts and underweight funds to chase.